“Scientists from Germany’s Jülich Research Centre are reporting successful results from the first phase of human clinical testing of a new Alzheimer’s drug. Following promising animal experiments the drug has initially now proved safe in human subjects and will soon move into Phase II clinical trials testing efficacy.